<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00968227</url>
  </required_header>
  <id_info>
    <org_study_id>07-0733</org_study_id>
    <secondary_id>NIH 5P50NS035966-10</secondary_id>
    <nct_id>NCT00968227</nct_id>
  </id_info>
  <brief_title>Effect of Red Blood Cell Transfusion on Brain Metabolism in Patients With Subarachnoid Hemorrhage</brief_title>
  <official_title>Effect of Red Blood Cell Transfusion on Brain Metabolism in Patients With Subarachnoid Hemorrhage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if giving blood transfusions to anemic patients&#xD;
      with subarachnoid hemorrhage will reduce their chances of having a stroke from vasospasm.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Each year, approximately 30,000 people suffer aneurysmal subarachnoid hemorrhage (SAH) in the&#xD;
      United States. The most common and potentially treatable cause of secondary neurological&#xD;
      injury in this population is delayed ischemic deficit (DID). As the name implies, this&#xD;
      phenomenon is fundamentally a reduction of cerebral blood flow (CBF) and oxygen delivery&#xD;
      below critical ischemic thresholds, occurring days after the onset of hemorrhage. Three&#xD;
      inter-related physiological processes appear to be involved in the reduced oxygen delivery:&#xD;
      severe narrowing of intracranial arteries (arterial vasospasm), intravascular volume&#xD;
      depletion and a loss of normal autoregulatory function in the distal circulation. DID occurs&#xD;
      in up to 40% of patients surviving SAH. One third of these patients will die from this&#xD;
      phenomenon and another third will be left with permanent and severe disability.&#xD;
&#xD;
      The optimal treatment of vasospasm is not known. Medical management involves a number of&#xD;
      hemodynamic manipulations and is usually referred to as hypervolemic, hypertensive,&#xD;
      hemodilution (or Triple-H) therapy. Our knowledge of the physiological impact of the&#xD;
      individual components or a combination of them is limited and clinical efficacy has not been&#xD;
      established. The information gained in this study has great potential to advance our&#xD;
      knowledge regarding the role of hematocrit in the optimal treatment of this often-devastating&#xD;
      condition.&#xD;
&#xD;
      Changes in hematocrit can potentially impact brain oxygen delivery in two ways. First, there&#xD;
      is a linear relationship between hemoglobin and arterial oxygen content, lower hematocrit&#xD;
      less oxygen. Thus at a given CBF lowering hematocrit reduces brain oxygen delivery.&#xD;
      Fortunately, the brain responds to this by increasing blood flow to restore oxygen delivery&#xD;
      to baseline levels. Additionally, lowering hematocrit has another effect, it reduces&#xD;
      viscosity which in and of itself can raise CBF, but in a non-linear way. It is the relative&#xD;
      contribution of these two effects that will determine if oxygen delivery improves.&#xD;
&#xD;
      It has been proposed by largely on theoretical consideration that the &quot;optimal&quot; hematocrit&#xD;
      that achieves this balance is 30-35%. Yet no study to date has assessed the relationship&#xD;
      between hematocrit and oxygen delivery in SAH patients. Other observations, however, suggest&#xD;
      that higher hemoglobin levels in SAH patients was associated with better outcomes. Finally&#xD;
      another retrospective review suggested that receiving transfusions increased risk for&#xD;
      vasospasm and poor outcome after subarachnoid hemorrhage.&#xD;
&#xD;
      We are proposing to begin a series of studies to determine the appropriate management of&#xD;
      hematocrit in SAH patients. The first is to define the appropriate physiologic response&#xD;
      (cerebral oxygen delivery and metabolism) to a change in hematocrit. Then the &quot;optimal&quot;&#xD;
      hematocrit can be defined. Only then will we be able to properly design clinical outcome&#xD;
      trials.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Oxygen Delivery in Vulnerable Brain Regions</measure>
    <time_frame>1 hour</time_frame>
    <description>Change in oxygen delivery after transfusion in brain regions with low baseline delivery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Oxygen Extraction Fraction in Regions With Low Baseline Delivery.</measure>
    <time_frame>1 hour</time_frame>
    <description>Change in oxygen extraction fraction after transfusion of 1 unit of RBC in regions with low baseline delivery (DO2 &lt; 4.5 ml/100g/min.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Subarachnoid Hemorrhage</condition>
  <condition>Vasospasm</condition>
  <arm_group>
    <arm_group_label>Transfusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Red blood cell transfusion</intervention_name>
    <description>Transfusion of 1 unit of packed red blood cells over 1 hour.</description>
    <arm_group_label>Transfusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Aneurysmal SAH confirmed by angiography&#xD;
&#xD;
          2. Hemoglobin &lt; 12.5 gm/dl&#xD;
&#xD;
          3. One of the following:&#xD;
&#xD;
               -  Considered at increased risk for vasospasm by care team&#xD;
&#xD;
               -  Angiographic vasospasm&#xD;
&#xD;
               -  Delayed ischemic deficit&#xD;
&#xD;
          4. Able to be studied within 2 weeks after subarachnoid hemorrhage&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Active Coronary Artery Disease&#xD;
&#xD;
          2. Severe congestive heart failure&#xD;
&#xD;
          3. Jehovah's witness&#xD;
&#xD;
          4. Unable to obtain appropriately matched blood&#xD;
&#xD;
          5. Other contraindications for transfusion&#xD;
&#xD;
          6. Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Diringer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Washington University Medical Center</name>
      <address>
        <city>St Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Dhar R, Zazulia AR, Videen TO, Zipfel GJ, Derdeyn CP, Diringer MN. Red blood cell transfusion increases cerebral oxygen delivery in anemic patients with subarachnoid hemorrhage. Stroke. 2009 Sep;40(9):3039-44. doi: 10.1161/STROKEAHA.109.556159. Epub 2009 Jul 23.</citation>
    <PMID>19628806</PMID>
  </results_reference>
  <verification_date>March 2017</verification_date>
  <study_first_submitted>August 26, 2009</study_first_submitted>
  <study_first_submitted_qc>August 27, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 28, 2009</study_first_posted>
  <results_first_submitted>March 5, 2017</results_first_submitted>
  <results_first_submitted_qc>March 5, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">April 17, 2017</results_first_posted>
  <last_update_submitted>March 5, 2017</last_update_submitted>
  <last_update_submitted_qc>March 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>subarachnoid hemorrhage</keyword>
  <keyword>vasospasm</keyword>
  <keyword>transfusion</keyword>
  <keyword>cerebral oxygen delivery</keyword>
  <keyword>hemoglobin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Transfusion</title>
          <description>Red blood cell transfusion: Transfusion of 1 unit of packed red blood cells over 1 hour.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Transfusion</title>
          <description>Red blood cell transfusion: Transfusion of 1 unit of packed red blood cells over 1 hour.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="56"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54" lower_limit="48" upper_limit="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Oxygen Delivery in Vulnerable Brain Regions</title>
        <description>Change in oxygen delivery after transfusion in brain regions with low baseline delivery.</description>
        <time_frame>1 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Transfusion</title>
            <description>Red blood cell transfusion: Transfusion of 1 unit of packed red blood cells over 1 hour.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Oxygen Delivery in Vulnerable Brain Regions</title>
          <description>Change in oxygen delivery after transfusion in brain regions with low baseline delivery.</description>
          <units>ml/100g/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post transfusion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>Paired t-test</non_inferiority_desc>
            <p_value>0.001</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Oxygen Extraction Fraction in Regions With Low Baseline Delivery.</title>
        <description>Change in oxygen extraction fraction after transfusion of 1 unit of RBC in regions with low baseline delivery (DO2 &lt; 4.5 ml/100g/min.</description>
        <time_frame>1 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Transfusion</title>
            <description>Red blood cell transfusion: Transfusion of 1 unit of packed red blood cells over 1 hour.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Oxygen Extraction Fraction in Regions With Low Baseline Delivery.</title>
          <description>Change in oxygen extraction fraction after transfusion of 1 unit of RBC in regions with low baseline delivery (DO2 &lt; 4.5 ml/100g/min.</description>
          <units>fraction</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.49" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post transfusion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.44" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Transfusion</title>
          <description>Red blood cell transfusion: Transfusion of 1 unit of packed red blood cells over 1 hour.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="56"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="56"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="56"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Michael Diringer PI</name_or_title>
      <organization>Washington University</organization>
      <phone>314-362-2999</phone>
      <email>diringerm@wustl.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

